The validity of systemic sclerosis diagnoses in two university hospitals in Finland. (2nd January 2023)

• Record Type: Journal Article
• Authors: Paltta, J; Kortelainen, S; Käyrä, M; Pirilä, L; Huhtakangas, J; Palomäki, A
• Is Part Of: Scandinavian journal of rheumatology. Volume 52:Number 1(2023)
• Page Start: 84
• Page End: 87
• Publication Date: 2023-01-02
• Subjects: Rheumatology -- Periodicals; Arthritis; Rheumatic Diseases; 616.72005
• DOI: 10.1080/03009742.2022.2056999
• Languages: English
• ISSNs: 0300-9742

Abstract

Abstract : Objective: This study aimed to determine the validity of systemic sclerosis (SSc) diagnoses in Finnish university hospitals. Method: Electronic medical records for 385 patients with a registered diagnosis of SSc (ICD-10 code M34) in two Finnish university hospitals from 2008 to 2018 were reviewed to assess whether each patient's diagnosis was correct. Results: The positive predictive value (PPV) of a diagnosis of SSc was 0.66 when fulfilment of the 2013 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for SSc was required; the PPV was 0.75 if patients meeting the 2001 LeRoy and Medsger classification criteria for early SSc were also included. When a diagnosis of SSc was made in a department of rheumatology, the PPV was 0.78, and 0.90 when including patients with early SSc. For the more specific diagnosis of limited cutaneous SSc (lcSSc), the PPV was 0.80, and 0.95 when including early SSc. For an lcSSc diagnosis made in rheumatology, the PPV was 0.81, and 0.97 with early SSc included. Conclusion: These results demonstrate that in these two Finnish university hospitals, the diagnostic validity of a diagnosis of SSc was good if it was diagnosed in the department of rheumatology. For a more specific diagnosis of lcSSc, the most prevalent form of SSc in Finland, the validity was good even when registered in any department.